Loading...

TYRA TYRA BIOSCIENCES INC Management Changes 8-K Filing

TYR

TYR

TYRA BIOSCIENCES INC

(TYRA)

2024 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Financial Results

Director Resignation

Equity Exchange

Financial Results Announcement

Annual Meeting and Liabilit...

Financial Results Announcement

Appointment of Directors

Earnings Reports

Private Placement

FDA Designation for TYRA-30...

Initiation of SURF201 Phase...

Earnings Reports

Amended and Restated Bylaws

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Incentive Plan Adoption and...

External Links:

Siddarth Subramony resigned from Tyra Biosciences' Board of Directors, and the company announced interim clinical results for TYRA-300 showing promising anti-tumor activity in patients with metastatic urothelial cancer, with a 100% disease control ra

AI Assistant

TYRA BIOSCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.